Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Davoud Ahmadvand

Showing results (11-20 of 53) with videos related to

Pageof 6
Sort By:
Expert Review of Vaccines|January 25, 2022
A comprehensive update to Dendritic Cell therapy for glioma: a systematic review and meta-analysisParisa Shamshiripour, Mehdi Nikoobakht, Zahra Mansourinejad, et al.
Journal of Biomolecular Screening|December 4, 2013
Identification and in vitro characterization of phage-displayed VHHs targeting VEGFZahra Farajpour, Fatemeh Rahbarizadeh, Bahram Kazemi, et al.
Journal of Immunoassay & Immunochemistry|September 12, 2012
Characterization and enzyme-conjugation of a specific anti-L1 nanobodySara Minaeian, Fatemeh Rahbarizadeh, Sayyed Hamid Zarkesh Esfahani, et al.
European Journal of Pharmaceutical Sciences : Official Journal of the European Federation for Pharmaceutical Sciences|June 23, 2018
Multivalent targeting and killing of HER2 overexpressing breast carcinoma cells with methotrexate-encapsulated tetra-specific non-overlapping variable domain heavy chain anti-HER2 antibody-PEG-liposomes: In vitro proof-of-conceptShahryar Khoshtinat Nikkhoi, Fatemeh Rahbarizadeh, Davoud Ahmadvand, et al.
Artificial Cells, Nanomedicine, and Biotechnology|September 25, 2018
Evaluation of cellular and transcriptional targeting of breast cancer stem cells via anti-HER2 nanobody conjugated PAMAM dendrimersAzadeh Reshadmanesh, Fatemeh Rahbarizadeh, Davoud Ahmadvand, et al.
Iranian Journal of Basic Medical Sciences|June 21, 2018
Development of specific nanobodies (VHH) for CD19 immuno-targeting of human B-lymphocytesSeyed Reza Banihashemi, Ahmad Zavaran Hosseini, Fatemeh Rahbarizadeh, et al.
Cellular and Molecular Bioengineering|November 14, 2019
Anti-HER2 VHH Targeted Magnetoliposome for Intelligent Magnetic Resonance Imaging of Breast Cancer CellsSepideh Khaleghi, Fatemeh Rahbarizadeh, Davoud Ahmadvand, et al.
Experimental Cell Research|September 13, 2011
Nanobody-based chimeric receptor gene integration in Jurkat cells mediated by φC31 integraseFarnoush Jafari Iri-Sofla, Fatemeh Rahbarizadeh, Davoud Ahmadvand, et al.
International Journal of Hematology|March 13, 2012
A caspase 8-based suicide switch induces apoptosis in nanobody-directed chimeric receptor expressing T cellsSepideh Khaleghi, Fatemeh Rahbarizadeh, Davoud Ahmadvand, et al.
Journal of Liposome Research|April 7, 2018
Effective suppression of tumour cells by oligoclonal HER2-targeted delivery of liposomal doxorubicinAlireza Farasat, Fatemeh Rahbarizadeh, Davoud Ahmadvand, et al.
Pageof 6

Showing results (11-20 of 53) with videos related to

Sort By:
Pageof 6
Expert Review of Vaccines|January 25, 2022
A comprehensive update to Dendritic Cell therapy for glioma: a systematic review and meta-analysisParisa Shamshiripour, Mehdi Nikoobakht, Zahra Mansourinejad, et al.
Journal of Biomolecular Screening|December 4, 2013
Identification and in vitro characterization of phage-displayed VHHs targeting VEGFZahra Farajpour, Fatemeh Rahbarizadeh, Bahram Kazemi, et al.
Journal of Immunoassay & Immunochemistry|September 12, 2012
Characterization and enzyme-conjugation of a specific anti-L1 nanobodySara Minaeian, Fatemeh Rahbarizadeh, Sayyed Hamid Zarkesh Esfahani, et al.
European Journal of Pharmaceutical Sciences : Official Journal of the European Federation for Pharmaceutical Sciences|June 23, 2018
Multivalent targeting and killing of HER2 overexpressing breast carcinoma cells with methotrexate-encapsulated tetra-specific non-overlapping variable domain heavy chain anti-HER2 antibody-PEG-liposomes: In vitro proof-of-conceptShahryar Khoshtinat Nikkhoi, Fatemeh Rahbarizadeh, Davoud Ahmadvand, et al.
Artificial Cells, Nanomedicine, and Biotechnology|September 25, 2018
Evaluation of cellular and transcriptional targeting of breast cancer stem cells via anti-HER2 nanobody conjugated PAMAM dendrimersAzadeh Reshadmanesh, Fatemeh Rahbarizadeh, Davoud Ahmadvand, et al.
Iranian Journal of Basic Medical Sciences|June 21, 2018
Development of specific nanobodies (VHH) for CD19 immuno-targeting of human B-lymphocytesSeyed Reza Banihashemi, Ahmad Zavaran Hosseini, Fatemeh Rahbarizadeh, et al.
Cellular and Molecular Bioengineering|November 14, 2019
Anti-HER2 VHH Targeted Magnetoliposome for Intelligent Magnetic Resonance Imaging of Breast Cancer CellsSepideh Khaleghi, Fatemeh Rahbarizadeh, Davoud Ahmadvand, et al.
Experimental Cell Research|September 13, 2011
Nanobody-based chimeric receptor gene integration in Jurkat cells mediated by φC31 integraseFarnoush Jafari Iri-Sofla, Fatemeh Rahbarizadeh, Davoud Ahmadvand, et al.
International Journal of Hematology|March 13, 2012
A caspase 8-based suicide switch induces apoptosis in nanobody-directed chimeric receptor expressing T cellsSepideh Khaleghi, Fatemeh Rahbarizadeh, Davoud Ahmadvand, et al.
Journal of Liposome Research|April 7, 2018
Effective suppression of tumour cells by oligoclonal HER2-targeted delivery of liposomal doxorubicinAlireza Farasat, Fatemeh Rahbarizadeh, Davoud Ahmadvand, et al.
Pageof 6